Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Novartis
Express Scripts
Merck
Fish and Richardson
US Army
US Department of Justice
Federal Trade Commission
Healthtrust
Fuji

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050680

« Back to Dashboard

NDA 050680 describes CLEOCIN, which is a drug marketed by Pharmacia And Upjohn and is included in fourteen NDAs. It is available from three suppliers. There is one patent protecting this drug. Additional details are available on the CLEOCIN profile page.

The generic ingredient in CLEOCIN is clindamycin palmitate hydrochloride. There are fifty-four drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the clindamycin palmitate hydrochloride profile page.
Summary for 050680
Tradename:CLEOCIN
Applicant:Pharmacia And Upjohn
Ingredient:clindamycin phosphate
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 050680
Ingredient-typeLincosamides
Physiological EffectDecreased Sebaceous Gland Activity
Suppliers and Packaging for NDA: 050680
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLEOCIN clindamycin phosphate CREAM;VAGINAL 050680 NDA Pharmacia and Upjohn Company LLC 0009-3448 0009-3448-01 1 TUBE, WITH APPLICATOR in 1 CARTON (0009-3448-01) > 40 g in 1 TUBE, WITH APPLICATOR
CLEOCIN clindamycin phosphate CREAM;VAGINAL 050680 NDA AUTHORIZED GENERIC Greenstone LLC 59762-5009 59762-5009-1 1 TUBE in 1 CARTON (59762-5009-1) > 40 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CREAM;VAGINALStrengthEQ 2% BASE
Approval Date:Aug 11, 1992TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CREAM;VAGINALStrengthEQ 2% BASE
Approval Date:Mar 2, 1998TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Julphar
McKesson
AstraZeneca
Colorcon
Accenture
Deloitte
Cipla
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot